Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from AbbVie Inc.

Advancing Toward Expanded Precision Treatment of KRAS-Mutated Lung, Colorectal, and other Solid Tumors

Release Date: July 21, 2021
Expiration Date: July 21, 2022

Activity Overview

This educational activity is an archive of the live virtual presentation held on July 20, 2021

For more information about this educational activity, please click here.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Amgen, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the mechanism of action of KRAS-targeted therapy in the context of KRAS-mutated tumor biology
  • Assess current and future applications of molecular testing strategies used to identify KRAS mutations across solid tumors
  • Evaluate efficacy and safety data from recent clinical trials investigating novel therapies for the management of KRAS-mutated solid tumors
  • Apply ongoing clinical trial inclusion criteria and emerging data to clinical scenarios for patients with KRAS-mutated solid tumors

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.


Gregory J. Riely, MD, PhD
Gregory J. Riely, MD, PhD
Vice-Chair, Clinical Research
Memorial Sloan Kettering Cancer Center
New York, NY

Ramaswamy Govindan, MD
Ramaswamy Govindan, MD
Professor of Medicine
Anheuser Busch Chair in Medical Oncology
Director, Section of Medical Oncology
Division of Oncology
Washington University School of Medicine
St. Louis, MO
Vamsidhar Velcheti, MD
Vamsidhar Velcheti, MD
Associate Professor, Department of Medicine
NYU Grossman School of Medicine
Director, Thoracic Med Oncology Program
NYU Langone Health
New York, NY

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By